Barinthus(US:BRNS) Globenewswireยท2025-10-07 21:30Core Insights - Class Action Attorney Juan Monteverde's firm, Monteverde & Associates PC, is investigating Barinthus Biotherapeutics plc regarding its merger with Clywedog Therapeutics, Inc. The firm has a strong reputation, having recovered millions for shareholders and being recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report [1]. Company Overview - Monteverde & Associates PC is headquartered in the Empire State Building, New York City, and specializes in class action securities litigation [2]. - The firm has a successful track record in trial and appellate courts, including the U.S. Supreme Court, indicating its capability in handling complex legal matters [2]. Merger Details - Under the proposed merger terms, Barinthus shareholders will receive one share of common stock in the new combined company for each American Depository Share or ordinary share owned. Clywedog shareholders will receive 4.358932 shares of common stock for each common or preferred share owned [1].